In NSCLC (non-small-cell lung carcinoma) patients (n = 76), CASC2 expression was downregulated proportionally to the pathological stage and associated with tumor size, and this gene was an independent predictor for overall survival [13]. Here, CASC2 is linked to non-small cell lung carcinoma.